The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells
- 1 April 2013
- journal article
- Published by Elsevier BV in Toxicology Letters
- Vol. 218 (2), 129-136
- https://doi.org/10.1016/j.toxlet.2012.11.006
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Glycogen Synthase Kinase-3β, NF-κB Signaling, and Tumorigenesis of Human OsteosarcomaJNCI Journal of the National Cancer Institute, 2012
- NF-κB as potential target in the treatment of melanomaJournal of Translational Medicine, 2012
- NF-κB, the first quarter-century: remarkable progress and outstanding questionsGenes & Development, 2012
- NF-κB addiction and its role in cancer: ‘one size does not fit all’Oncogene, 2010
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasionBritish Journal of Cancer, 2010
- Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall‐cell lung cancer, or pancreatic cancerCancer, 2009
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-κB, and Glucose RegulationCancer Research, 2008
- The IκB kinase complex: master regulator of NF-κB signalingImmunologic Research, 2008
- Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic lymphocytic leukemia B cellsBlood, 2007
- The inhibitors of apoptosis (IAPs) as cancer targetsApoptosis, 2007